Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chrysalin in fractured distal radius
NCT00131482Phase 2Terminated
- Sponsor
- OrthoLogic Corp.
- Start
- Nov 2004
- Primary completion
- Mar 2007
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rusalatide in distal radius fracture (5 arms), sponsored by OrthoLogic Corp. Primary endpoint: Time to removal of all rigid immobilization for fracture at Week 26. Started Nov 2004; status: terminated.
02
Drugs
rusalatide
03
Conditions
distal radius fracture
Beyond the preview
Go deeper on NCT00131482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00131482.